A multicenter, prospective sibling oocyte study revealed that HyperSperm™ improves the number and quality of embryos in patients undergoing in vitro fertilization.
First multicenter sibling oocyte study in IVF patients supporting the clinical potential of HyperSperm.
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking “Accept All”, you consent to our use of cookies.
You can change or withdraw your consent at any time using the privacy settings button.
